Variant report

Variant	rs10189991
Chromosome Location	chr2:9892899-9892900
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:9886336..9889527-chr2:9892124..9895525,3	MCF-7	breast:
2	chr2:9891910..9893733-chr2:9895279..9898420,3	MCF-7	breast:
3	chr2:9892798..9893661-chr3:149530498..149531325,2	Hela-S3	cervix:
4	chr2:9891163..9893022-chr2:9896031..9898454,2	K562	blood:
5	chr10:92980146..92980794-chr2:9892579..9893415,2	Hela-S3	cervix:
6	chr2:9772230..9774093-chr2:9892101..9894340,2	MCF-7	breast:
7	chr2:9892015..9895829-chr2:9904744..9907713,4	K562	blood:
8	chr2:9892015..9894940-chr2:9904744..9907619,3	K562	blood:
9	chr2:9769789..9771364-chr2:9892124..9894482,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000082996	Chromatin interaction
ENSG00000240960	Chromatin interaction
ENSG00000134308	Chromatin interaction
ENSG00000180628	Chromatin interaction

Extended variants
information (count: 24 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:16)

rs_ID	r²[population]
rs11889675	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12329266	1.00[JPT][hapmap];0.85[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs12619723	0.87[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs13393165	0.93[CEU][hapmap];0.95[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs13406396	0.83[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs13412895	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs16867150	0.84[EUR][1000 genomes]
rs16867153	0.85[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs16867155	0.85[CEU][hapmap];1.00[JPT][hapmap];0.83[EUR][1000 genomes]
rs4145374	0.85[CEU][hapmap];0.94[JPT][hapmap];0.83[EUR][1000 genomes]
rs55683574	0.82[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs55831980	0.82[AMR][1000 genomes];0.91[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs67071207	0.84[AMR][1000 genomes];0.97[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs67169917	0.84[AMR][1000 genomes];0.97[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs72779090	0.82[AMR][1000 genomes];0.92[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs72779094	0.83[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv469405	chr2:9814374-9964947	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	26 gene(s)	inside rSNPs	diseases
2	nsv580930	chr2:9814374-9964947	Enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	26 gene(s)	inside rSNPs	diseases
3	nsv1003026	chr2:9854939-10012516	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	34 gene(s)	inside rSNPs	diseases
4	nsv470443	chr2:9857018-9975557	Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	23 gene(s)	inside rSNPs	diseases
5	nsv1014911	chr2:9863969-9905959	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
6	nsv873618	chr2:9870631-9919759	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases
7	nsv873619	chr2:9870631-9956981	Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	inside rSNPs	diseases
8	nsv1013969	chr2:9888703-10023951	Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS Weak transcription ZNF genes & repeats Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:84 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:9880200-9893200	Weak transcription	Right Atrium	heart
2	chr2:9885200-9893000	Weak transcription	Rectal Mucosa Donor 29	rectum
3	chr2:9885400-9893000	Weak transcription	Left Ventricle	heart
4	chr2:9888600-9893000	Enhancers	GM12878-XiMat	blood
5	chr2:9889400-9893200	Weak transcription	Rectal Mucosa Donor 31	rectum
6	chr2:9889800-9896800	Enhancers	Skeletal Muscle Female	skeletal muscle
7	chr2:9890600-9893000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
8	chr2:9890800-9894200	Enhancers	Skeletal Muscle Male	skeletal muscle
9	chr2:9890800-9895800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
10	chr2:9891000-9895800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
11	chr2:9891400-9893000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
12	chr2:9891400-9893000	Enhancers	Esophagus	oesophagus
13	chr2:9891600-9893000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr2:9891600-9893000	Weak transcription	Right Ventricle	heart
15	chr2:9891600-9896800	Weak transcription	Psoas Muscle	Psoas
16	chr2:9891800-9893000	Weak transcription	Fetal Heart	heart
17	chr2:9892000-9893000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr2:9892000-9893000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
19	chr2:9892000-9893000	Enhancers	HMEC	breast
20	chr2:9892000-9894200	Enhancers	Primary monocytes fromperipheralblood	blood
21	chr2:9892000-9897800	Bivalent Enhancer	Fetal Muscle Leg	muscle
22	chr2:9892400-9893000	Enhancers	Primary T helper cells PMA-I stimulated	--
23	chr2:9892400-9895600	Enhancers	Primary T helper cells fromperipheralblood	blood
24	chr2:9892400-9898600	Enhancers	Primary hematopoietic stem cells short term culture	blood
25	chr2:9892600-9893000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr2:9892600-9893000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr2:9892600-9893000	Enhancers	Primary B cells from cord blood	blood
28	chr2:9892600-9893000	Enhancers	Primary B cells from peripheral blood	blood
29	chr2:9892600-9893000	Enhancers	Primary T helper naive cells from peripheral blood	blood
30	chr2:9892600-9893000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr2:9892600-9893000	Enhancers	Duodenum Mucosa	Duodenum
32	chr2:9892600-9893000	Enhancers	NH-A	brain
33	chr2:9892600-9893000	Enhancers	NHDF-Ad	bronchial
34	chr2:9892600-9893000	Enhancers	NHLF	lung
35	chr2:9892600-9893200	Bivalent Enhancer	Adipose Nuclei	Adipose
36	chr2:9892600-9893200	Enhancers	K562	blood
37	chr2:9892600-9893600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
38	chr2:9892600-9893600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
39	chr2:9892600-9893800	Enhancers	H9 Cell Line	embryonic stem cell
40	chr2:9892600-9893800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr2:9892600-9893800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr2:9892600-9893800	Flanking Bivalent TSS/Enh	HepG2	liver
43	chr2:9892600-9893800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
44	chr2:9892600-9893800	Flanking Active TSS	Osteobl	bone
45	chr2:9892600-9894200	Enhancers	Breast Myoepithelial Primary Cells	Breast
46	chr2:9892600-9894200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
47	chr2:9892600-9894400	Flanking Active TSS	A549	lung
48	chr2:9892600-9894600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr2:9892600-9894600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr2:9892600-9894600	Enhancers	Primary T killer naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links